Ibandronate Sodium
NDC 60505-6097, ibandronate sodium, injection, from Apotex Corp..
- Product NDC
- 60505-6097
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204222
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6097 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBANDRONATE SODIUM3 mg/3mL
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6097-0 | 60505609700 | 1 SYRINGE, GLASS in 1 CARTON (60505-6097-0) / 3 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9fad4982-95af-d711-f50a-867311835143Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=60505-6097NADAC price for package 60505609700
GET /v1/drugs/nadac/60505609700
Use it
Look up 60505-6097 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6097 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6097. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.